Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BMS-986488 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on BMS-986488 (Jan 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BMS-986488 | BMS986488|BMS 986488 | Limited information is currently available on BMS-986488 (Jan 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06764771 | Phase I | Adagrasib + BMS-986488 + Cetuximab BMS-986488 + Nivolumab BMS-986488 Adagrasib + BMS-986488 | A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors | Recruiting | USA | CAN | AUS | 0 |